Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that Intellia Therapeutics (NTLA) hired Laura Sepp-Lorenzino as executive vice president and chief scientific officer. Previously, she worked at Vertex (VRTX) Pharmaceuticals (VRTX), where she was vice president, head of nucleic acid therapies, research leadership.